News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProImmune Limited Introduces ProStorm™ In-Vitro Assay Service


9/18/2012 8:49:42 AM

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd., a leader in services for understanding immune responses, announced today the commercial launch of ProStorm™, an in vitro cytokine release assay, which can help assess the likelihood of first infusion reactions to novel therapeutics. ProStorm™ offers drug developers an improved route to risk identification prior to initiating clinical trials in man.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES